Vote Yes
An Act to establish a national framework on food allergy
This bill supports safer, healthier lives and modest productivity gains while promoting research and innovation, with limited fiscal exposure. The economic effects are indirect, so execution should prioritize safety outcomes without imposing unnecessary regulatory burdens on producers and health systems.
What is the projected cost and delivery timeline to ensure reliable access to epinephrine devices across Canada, and how will affordability be guaranteed for low-income families without creating new barriers?
How will the framework avoid duplicating provincial and territorial programs and instead set clear, measurable targets for diagnosis wait times and early-allergen prevention uptake, with public reporting by region?
If changes to ingredient information are contemplated, will the government harmonize with international standards to protect consumers while minimizing compliance burdens on small and medium-sized food processors?
Improved health can modestly support prosperity, but macroeconomic impacts are indirect and limited.
A national framework may streamline guidance, but potential future labeling or access requirements could add compliance; net effect is unclear.
Reducing allergic incidents and improving access to treatment can decrease absenteeism and improve workforce participation.
No direct export or trade provisions.
Explicitly supports research and innovation in prevention and treatment, encouraging health-tech and clinical advances.
Central coordination and unpaid advisory board could reduce fragmentation, but added reporting and processes may increase administrative workload.
No tax measures are included.
Important for public health and safety, but not a transformative economic initiative.
Did we get the builder vote wrong?
Email hi@buildcanada.com